Kazuhiro Kakimi

7.4k total citations
160 papers, 5.6k citations indexed

About

Kazuhiro Kakimi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kazuhiro Kakimi has authored 160 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Immunology, 82 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Kazuhiro Kakimi's work include Immunotherapy and Immune Responses (74 papers), Cancer Immunotherapy and Biomarkers (62 papers) and Immune Cell Function and Interaction (51 papers). Kazuhiro Kakimi is often cited by papers focused on Immunotherapy and Immune Responses (74 papers), Cancer Immunotherapy and Biomarkers (62 papers) and Immune Cell Function and Interaction (51 papers). Kazuhiro Kakimi collaborates with scholars based in Japan, United States and China. Kazuhiro Kakimi's co-authors include Francis V. Chisari, Luca G. Guidotti, Hirokazu Matsushita, Yasuhiko Koezuka, Jun Nakajima, Stefan Wieland, Satoshi Ueha, Kouji Matsushima, Akihiro Hosoi and Makoto Kurachi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Kazuhiro Kakimi

155 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuhiro Kakimi Japan	42	3.6k	2.3k	1.2k	997	804	160	5.6k
Pablo Sarobe Spain	39	2.6k 0.7×	2.0k 0.9×	935 0.8×	1.5k 1.5×	1.5k 1.9×	125	5.5k
Baogong Zhu United States	12	4.0k 1.1×	2.2k 1.0×	873 0.7×	763 0.8×	333 0.4×	15	5.5k
Jaap Kwekkeboom Netherlands	44	2.8k 0.8×	1.7k 0.8×	1.1k 1.0×	1.4k 1.4×	1.2k 1.5×	161	6.0k
Kevin F. Staveley-O’Carroll United States	35	2.5k 0.7×	2.1k 0.9×	737 0.6×	1.4k 1.4×	341 0.4×	124	5.0k
Masaki Terabe United States	42	4.7k 1.3×	2.4k 1.1×	650 0.6×	1.6k 1.6×	245 0.3×	101	6.5k
Su‐Hyung Park South Korea	36	1.9k 0.5×	1.2k 0.5×	946 0.8×	818 0.8×	884 1.1×	116	4.2k
Dietmar Zehn Germany	38	5.7k 1.6×	3.5k 1.5×	674 0.6×	1.4k 1.5×	252 0.3×	84	7.5k
Junliang Fu China	29	2.2k 0.6×	915 0.4×	1.8k 1.6×	619 0.6×	1.6k 2.0×	90	4.7k
Jean‐Pierre Abastado France	41	3.1k 0.9×	1.3k 0.6×	572 0.5×	1.3k 1.3×	208 0.3×	95	4.8k

Countries citing papers authored by Kazuhiro Kakimi

Since Specialization

Citations

This map shows the geographic impact of Kazuhiro Kakimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Kakimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Kakimi more than expected).

Fields of papers citing papers by Kazuhiro Kakimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiro Kakimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Kakimi. The network helps show where Kazuhiro Kakimi may publish in the future.

Co-authorship network of co-authors of Kazuhiro Kakimi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Kakimi. A scholar is included among the top collaborators of Kazuhiro Kakimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Kakimi. Kazuhiro Kakimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murakami, Kosuke, Shiki Takamura, Kazuhiro Kakimi, & Noriomi Matsumura. (2025). Tumor immunology and immunotherapy for endometrial cancer. Expert Opinion on Investigational Drugs. 34(1-2). 37–48. 1 indexed citations

Kawakami, Hisato, Shigenori Kadowaki, Akitaka Makiyama, et al.. (2025). Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer. Journal of Clinical Oncology. 43(19). 2184–2195. 2 indexed citations

Li, Yang, Yoshimitsu Sakamoto, Lin Xie, et al.. (2024). Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody. Neoplasia. 60. 101099–101099. 2 indexed citations

Sasagawa, Shota, Yoshitaka Honma, Xinxin Peng, et al.. (2024). Predicting chemotherapy responsiveness in gastric cancer through machine learning analysis of genome, immune, and neutrophil signatures. Gastric Cancer. 28(2). 228–244. 4 indexed citations

Chen, Pengwen, et al.. (2024). Nanoenabled IL-15 Superagonist via Conditionally Stabilized Protein–Protein Interactions Eradicates Solid Tumors by Precise Immunomodulation. Journal of the American Chemical Society. 146(47). 32431–32444. 1 indexed citations

Matsushita, Hirokazu, Tuan Zea Tan, Daisuke Shintani, et al.. (2023). Analyses of tumor microenvironment affecting the survival in patients with ovarian cancer receiving intraperitoneal chemotherapy: Translational research from the phase 3 trial of intraperitoneal therapy for ovarian cancer with carboplatin (TRiPocc).. Journal of Clinical Oncology. 41(16_suppl). 5555–5555. 1 indexed citations

Chen, Pengwen, Wenqian Yang, Koji Nagaoka, et al.. (2023). An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors. Advanced Science. 10(10). e2205139–e2205139. 27 indexed citations

Maeda, Yuka, Hisashi Wada, Daisuke Sugiyama, et al.. (2021). Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nature Communications. 12(1). 7280–7280. 29 indexed citations

Sakamoto, Yoshimitsu, Ken Ando, Hidetoshi Fujita, et al.. (2021). Th Balance–Related Host Genetic Background Affects the Therapeutic Effects of Combining Carbon-Ion Radiation Therapy With Dendritic Cell Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 112(3). 780–789. 8 indexed citations

10.

Nagaoka, Koji, Changbo Sun, Yukari Kobayashi, et al.. (2021). Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy. Cancers. 14(1). 106–106. 11 indexed citations

11.

Matsushita, Hirokazu, Yusuke Sato, Takahiro Karasaki, et al.. (2016). Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Immunology Research. 4(5). 463–471. 74 indexed citations

12.

Kurose, Koji, Yoshihiro Ohue, Hisashi Wada, et al.. (2015). Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients. Clinical Cancer Research. 21(19). 4327–4336. 179 indexed citations

13.

Ueha, Satoshi, Shoji Yokochi, Yoshiro Ishiwata, et al.. (2015). Robust Antitumor Effects of Combined Anti–CD4-Depleting Antibody and Anti–PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice. Cancer Immunology Research. 3(6). 631–640. 60 indexed citations

14.

Makise, Naohiro, Teppei Morikawa, Tohru Nakagawa, et al.. (2015). MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma. Human Pathology. 50. 62–69. 6 indexed citations

15.

Matsushita, Hirokazu, Akihiro Hosoi, Satoshi Ueha, et al.. (2014). Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest. Cancer Immunology Research. 3(1). 26–36. 88 indexed citations

16.

Futami, Junichiro, Rie Kinoshita, Tomoko Honjo, et al.. (2014). Denatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water. PLoS ONE. 9(11). e113295–e113295. 8 indexed citations

17.

Shimizu, Kanako, Takuya Mizuno, Jun Shinga, et al.. (2012). Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells. Cancer Research. 73(1). 62–73. 32 indexed citations

18.

Kurachi, Makoto, Fumiko Suenaga, Tatsuya Tsukui, et al.. (2011). Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. The Journal of Experimental Medicine. 208(8). 1605–1620. 150 indexed citations

19.

Uno, Kazuko, Mayumi Hirosaki, Kazuhiro Kakimi, et al.. (2007). Impaired IFN- α Production and the Risk of Cancer Development. Journal of Interferon & Cytokine Research. 27(12). 1013–1018. 7 indexed citations

20.

Uno, Kazuko, Takayuki Sato, Yoshihiro Takada, et al.. (1998). A Bioassay for Serum Interferon Based on Induction of 2′5′-Oligoadenylate Synthetase Activity. Journal of Interferon & Cytokine Research. 18(12). 1011–1018. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact